Clinical features and treatment strategies for older prostate cancer patients with bone metastasis - Abstract

To identify the clinical features and independent predictors of survival in older patients with bone metastasis from prostate cancer (PCa).

We retrospectively analysed 205 older patients with bone metastases from PCa between 1997 and 2012. The Kaplan-Meier method was used with the log-rank test for survival rate calculations and to evaluate each variable. Multivariate analysis was performed with the Cox regression model. The chi-squared test was used to compare survival rates between older and younger (n=197) patients. All patients were followed up. The 1-, 2-, 3- and 5-year survival rates were 95.5%, 77.5%, 68.5% and 33.7%, respectively. Gleason score, radiotherapy of the primary tumour, the number of bone metastases, the alkaline phosphatase alkaline phosphatase (ALP) level, organ metastasis and regional lymph node metastasis were associated with the survival rates. Multivariate Cox regression analysis showed that Gleason score at diagnosis of the primary tumour was a significant predictor of overall survival following the diagnosis of bone metastases. In addition, the overall survival rates of older patients were higher compared with younger patients, but older patients who underwent radiotherapy had higher mortality. These data may serve as a guide for creating clinical prediction models in further studies.

Written by:
Yang C, Qi GS, Rong RM, He J.   Are you the author?
Department of Urology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Reference: Asian J Androl. 2013 Sep 16. Epub ahead of print.
doi: 10.1038/aja.2013.111


PubMed Abstract
PMID: 24036918

UroToday.com Bone Metastases Section